Poster Session 13: Anti-IgE

Monday, 5 December 2011: 12:15 - 14:15
Poster Hall (Cancún Center)
2116
REFRACTORY CHRONIC Urticaria Treated with Omalizumab | Martinez Saenz (Mexico)
2117
Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy | Arzu Didem Yalcin (Turkey)
2118
Evaluation of Adverse Events Associated to Administration of Omalizumab | R Maximiliano Gomez (Argentina)
2119
Gender and Different Prevalence in Asthma Treatment with Anti-IgE (omalizumab) | Vincenzo Patella (Italy)
2120
Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab - Case Report | Fábio Kuschnir (Brazil)
2121
Vasculitic Urticaria Treated with Omalizumab. Case Report | María Elena Ramírez Del Pozo (Mexico)
2122
Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report Massimo Triggiani (Italy)
2123
A 4-Year Follow-up in Children with Moderate/Severe Asthma After Withdrawal 1 Year Omalizumab Treatment | Alvaro Teijeiro (Argentina)
2124
Serum Soluble TRAIL Levels In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)
2125
Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)
2126
Near-Fatal Asthma Treated with Omalizumab | Elvia Angelica Contreras Contreras (Mexico)
2127
Use of Omalizumab In Chronic Moderate to Severe Persistent Asthma-An Indian Experience | Qamar Ansari (India)
2128
Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic | Jorge Vargas Correa (Mexico)
See more of: Poster Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>